RYR2 and catecholaminergic polymorphic ventricular tachycardia: As a consequence, we have concluded that the mechanism of action of flecainide in CPVT depends on its ability to block Na+ channels and does not involve a direct action on RyR2 channels (Bannister et al., 2015).